Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
APLIF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
nasdaq.comPOSITIVO
Appili Therapeutics Q3 Loss Increases
(RTTNews) - Appili Therapeutics (APLIF) reported Loss for its third quarter of -C$0.95 million The company's earnings totaled -C$0.95 million, or -C$0.01 per share. This compares with -C$0.52 million, or -C$0.004 per share, last year. The…
(RTTNews) - Appili Therapeutics (APLIF) revealed Loss for second quarter of -C$0.99 million The company's bottom line came in at -C$0.99 million, or -C$0.01 per share. This compares with -C$0.74 million, or -C$0.01 per share, last year. Th…
Appili Therapeutics Announces New Late-Stage Clinical Program ATI-1801 to Treat Cutaneous Leishmaniasis
Topical formulation of paromomycin ATI-1801 already shown to be safe and effective against the disfiguring disease in Phase 3 study ATI-1801 may be eligible for tropical disease priority review voucher if approved by FDA HALIFAX, Nova Scot…
Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing
Virtual Investor Conferences NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the March 10th Life Sciences Investor F…
UPDATE – Life Sciences Investor Forum: Company Executives Present Live March 10th
Virtual Investor Conferences Company Executives share vision and answer questions live at VirtualInvestorConferences.com NEW YORK, March 08, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference…